Erick Lucera, EVP, CHIEF FINANCIAL OFFICER at Editas Medicine, Inc. (EDIT), sold 44,674 shares at $5.61 ($251K) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Scheduled sale ($251k) by EVP, CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.61 | 22,337 | $125K | 50.0% |
| 2 | $5.61 | 22,337 | $125K | 50.0% |
| Total | $5.61 avg | 44,674 | $251K | 100% |
| Filing → |
| DYN | SELL | 2026-05-14 | $27K | — | Filing → |
| DYN | SELL | 2026-04-03 | $107K | — | Filing → |
| EDIT | SELL | 2025-03-05 | $7K | — | Filing → |